Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound eyebrow lift shows promise in clinical trial

NCT ID NCT06724510

Symptom relief Sponsor: CLASSYS Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed clinical trial tested a high-intensity focused ultrasound (HIFU) device called ULTRAFORMER MPT for lifting eyebrows without surgery. 180 adults aged 20-65 with mild to moderate forehead skin laxity received either a single HIFU treatment or no treatment. The study measured eyebrow lifting improvement using standardized photos and participant satisfaction over 3 months. Results suggest the device can effectively lift brows with an acceptable safety profile.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-intensity focused ultrasound (HIFU) device (ULTRAFORMER MPT)
What this could lead to
If proven effective, this device could offer a non-surgical option for lifting eyebrows, reducing the need for invasive procedures.
What could go wrong
This is a small, completed trial with short follow-up (3 months). Results may not last long-term, and individual results vary. Pain or temporary skin reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

180 people

The number who actually took part.

Started

Nov 2024

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age: 20 to 65 years old at the time of consent. 2. Condition: Forehead skin laxity with Forehead Lines Grading Scale score of 1-3. 3. Consent: Ability to understand trial details, voluntarily participate, and comply with treatment and follow-up. Exclusion Criteria: 1. Skin Conditions: Hyperpigmentation, tattoos, scars, active skin diseases, or other conditions (e.g., eczema, psoriasis, vitiligo) in the treatment area that may affect efficacy or increase risk. 2. Medical Devices or Implants: Presence of metal implants or embedded electronic devices in the treatment area. 3. Health Conditions: Severe dysfunction of vital organs (e.g., heart, liver, kidneys), autoimmune diseases, or uncontrolled diabetes. 4. Medications: Recent use of anti-thrombotic agents, NSAIDs, or other drugs affecting coagulation within one week before screening. 5. Prior Treatments: Use of fillers (e.g., hyaluronic acid, collagen) or cosmetic procedures (e.g., laser therapy, botulinum toxin) in the treatment area within the specified timeframes. 6. Pregnancy: Women who are pregnant, nursing, or not using birth control during the trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial wrinkles and rhytides reduction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cutis laxa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial wrinkles and rhytides reduction Skin laxity Wrinkles

Contacts and locations

Locations

  • Beijing Anzhen Hospital of Capital Medical University

    Beijing, China

  • Emergency General Hospital

    Beijing, China

  • The Second Affiliated Hospital of Xian Jiaotong University

    Xi'an, China

  • TheThird Hospital of Hebei Medical University

    Shijiazhuang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.